IL-23 is required for the development of severe egg-induced immunopathology in schistosomiasis and for lesional expression of IL-17

被引:80
|
作者
Rutitzky, Laura I. [1 ]
Bazzone, Lindsey [1 ]
Shainheit, Mara G. [1 ]
Joyce-Shaikh, Barbara [2 ]
Cua, Daniel J. [2 ]
Stadecker, Miguel J. [1 ]
机构
[1] Tufts Univ, Sch Med, Dept Pathol, Boston, MA 02111 USA
[2] Schering Plough Biopharma, Palo Alto, CA 94304 USA
来源
JOURNAL OF IMMUNOLOGY | 2008年 / 180卷 / 04期
关键词
D O I
10.4049/jimmunol.180.4.2486
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In infection with the trematode helminth Schistosoma mansoni, the severity of CD4 T cell-mediated hepatic granulomatous and fibrosing inflammation against parasite eggs varies considerably in humans and among mouse strains. In mice, either the natural high pathology, or high pathology induced by concomitant immunization with schistosome egg Ags (SEA) in CFA (SEA/CFA), results from a failure to contain a net proinflammatory cytokine environment. We previously demonstrated that the induction of severe immunopathology was dependent on the IL-12/IL-23 common p40 subunit, and correlated with an increase in IL-17, thus implying IL-23 in the pathogenesis. We now show that mice lacking the IL-23-specific subunit p19 are impaired in developing severe immunopathology following immunization with SEA/CFA, which is associated with a marked drop of IL-17 in the granulomas, but not in the draining mesenteric lymph nodes, and with a markedly suppressed SEA-specific IFN-gamma response regulated by a striking increase in IL-10. The granulomas are characterized by a significant reduction in Gr-1(+) cell recruitment and by alternative macrophage activation. Taken together, these results demonstrate that IL-23 per se is not necessary for the generation of IL-17-producing T cells, but is essential for the development of severe schistosome egg-induced immunopathology, and its absence cannot be overcome with other possible compensatory mechanisms.
引用
收藏
页码:2486 / 2495
页数:10
相关论文
共 50 条
  • [21] IL-23/IL-17 Axis in Inflammatory Rheumatic Diseases
    Li, Hao
    Tsokos, George C.
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2021, 60 (01) : 31 - 45
  • [22] The Role of IL-23/IL-17 Axis in Lupus Nephritis
    Zhang, Zheng
    Kyttaris, Vasileios C.
    Tsokos, George C.
    JOURNAL OF IMMUNOLOGY, 2009, 183 (05): : 3160 - 3169
  • [23] IL-23/IL-17 Axis in Inflammatory Rheumatic Diseases
    Hao Li
    George C. Tsokos
    Clinical Reviews in Allergy & Immunology, 2021, 60 : 31 - 45
  • [24] Effects of the IL-23–IL-17 pathway on bone in spondyloarthritis
    Ellen M. Gravallese
    Georg Schett
    Nature Reviews Rheumatology, 2018, 14 : 631 - 640
  • [25] Therapeutic potential of targeting IL-17 and IL-23 in sepsis
    Bosmann, Markus
    Ward, Peter A.
    CLINICAL AND TRANSLATIONAL MEDICINE, 2012, 1
  • [26] IL-23, rather than IL-17, is crucial for the development of ovalbumin-induced allergic rhinitis
    Guo, Chaobin
    Chen, Guie
    Ge, Ruifeng
    MOLECULAR IMMUNOLOGY, 2015, 67 (02) : 436 - 443
  • [27] Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis
    Ghoreschi, Kamran
    Balato, Anna
    Enerback, Charlotta
    Sabat, Robert
    LANCET, 2021, 397 (10275): : 754 - 766
  • [28] Erratum: The IL-23–IL-17 axis in inflammatory arthritis
    Erik Lubberts
    Nature Reviews Rheumatology, 2015, 11 : 562 - 562
  • [29] The Role of the IL-23/IL-17 Pathway in the Pathogenesis of Spondyloarthritis
    Tsukazaki, Hiroyuki
    Kaito, Takashi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (17) : 1 - 19
  • [30] Exacerbated egg-induced immunopathology in murine Schistosoma mansoni infection is primarily mediated by IL-17 and restrained by IFN-γ
    Rutitzky, Laura I.
    Stadecker, Miguel J.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2011, 41 (09) : 2677 - 2687